Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008625
Abstract: Finding safe and effective treatment strategies for patients with TP53 -mutated acute myeloid leukemia (AML) remains an important unmet need. read more here.
Keywords: mutated aml; older patients; patients tp53; pevonedistat azacitidine ... See more keywords